2023
Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history
Wang C, Tian X, Feng X, Demuyakor A, Hu S, Wang Y, Li L, Cui L, Dong F, Dai J, Lei F, Xu Y, Du Z, Shi M, Liu J, Xing L, E M. Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history. Atherosclerosis 2023, 378: 117118. PMID: 37127496, DOI: 10.1016/j.atherosclerosis.2023.03.023.Peer-Reviewed Original ResearchConceptsAcute coronary syndrome patientsAcute coronary syndromeMaximum lipid arcOptical coherence tomographyThin-cap fibroatheromaCancer historyFibrous cap thicknessPercutaneous coronary interventionNonculprit lesionsLipid arcPrevalence of high-risk plaqueIncidence of thin-cap fibroatheromaCulprit lesionPrevalence of acute coronary syndromeHigh-risk plaque featuresHigher incidencePlaque characteristicsTime of percutaneous coronary interventionAssociated with high mortalityCharacteristics of coronary plaquesLipid indicesAbsence of cancer historyCoronary syndrome patientsNon-culprit lesionsIncidence of calcification
2021
Impact of nodular calcification on the outcomes of patients with acute coronary syndrome (ACS) treated with primary percutaneous coronary intervention (PCI)
Demuyakor A, Hu S, Koniaeva E, Liu M, Weng Z, Zhao C, Feng X, He L, Xu Y, Zeng M, Meng W, Yi B, Qin Y, Jia H, Bo Y. Impact of nodular calcification on the outcomes of patients with acute coronary syndrome (ACS) treated with primary percutaneous coronary intervention (PCI). European Heart Journal 2021, 42: ehab724.1249. DOI: 10.1093/eurheartj/ehab724.1249.Peer-Reviewed Original ResearchAcute coronary syndromePercutaneous coronary interventionPrimary percutaneous coronary interventionOutcomes of patientsCalcification groupOptical coherence tomographyNodular calcificationCoronary syndromeMinimum stent areaCoronary interventionLower left ventricular ejection fractionPresence of nodular calcificationTreated with primary percutaneous coronary interventionAssociated with unfavourable outcomeIncidence of stentsAcute coronary syndrome patientsVentricular ejection fractionLesion lengthImpact clinical outcomesEjection fractionIndependent predictorsProtruding massClinical outcomesUnfavourable outcomeResults Patients
2017
SYSTEMIC PENTRAXIN 3 IS A POTENTIAL BIOMARKER TO DIFFERENTIATE PLAQUE EROSION FROM PLAQUE RUPTURE IN ACUTE CORONARY SYNDROME PATIENTS
Mustafina I, Hu S, Jia H, Zheng G, Liu W, Li L, Zhu Y, Wang C, Afolabi A, Zhe C, Wang Y, Dong H, Zhang X, Lin L, Fu Y, Zhang S, Liu Y, Zhang S, Zagidullin N, Jang I, Yu B. SYSTEMIC PENTRAXIN 3 IS A POTENTIAL BIOMARKER TO DIFFERENTIATE PLAQUE EROSION FROM PLAQUE RUPTURE IN ACUTE CORONARY SYNDROME PATIENTS. Journal Of The American College Of Cardiology 2017, 69: 1280. DOI: 10.1016/s0735-1097(17)34669-7.Peer-Reviewed Original Research